美女免费一级视频在线观看
AbbVie is set to buy Gilgamesh Pharmaceuticals’ psychedelic drug for up to $1.2 billion. The drug is aimed at treating major depression. (STAT News)
The Centers for Disease Control and Prevention tapped Retsef Levi, a vaccine skeptic, to lead a key vaccine panel. Levi will lead the COVID-19 immunization workgroup. (Reuters)
Royalty Pharma acquired an $885 million royalty interest in Amgen’s Imdelltra. The drug launched in 2024 and targets small cell lung cancers. (Yahoo! Finance)
Health and Human Services Secretary Robert F. Kennedy Jr. along with the Trump administration are allegedly planning to further roll back the COVID vaccine. It is reported that the vaccine may be rolled back within the next few months. (Newsweek)
The Food and Drug Administration has been speeding up its publishing of adverse data potentially linked to drugs and vaccines, according to reports. The department has gone from issuing quarterly to daily updates about drugs and vaccines. (Endpoints News)
To read yesterday’s edition of Five things for pharma marketers to know, click here.